Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 82,796 | 84,193 | +1,397 | $27.72M | $24.52M | 18.92% | -$3.20M |
| Whitehawk Therapeutics Inc | 4,685,912 | 4,685,912 | 0 | $21.46M | $17.62M | 13.60% | -$3.84M |
| Tango Therapeutics, Inc.(TNGX) | 390,949 | 409,529 | +18,580 | $12.22M | $10.22M | 7.88% | -$2.00M |
| 4d Molecular Therapeutics In | 507,801 | 535,109 | +27,308 | $6.75M | $7.66M | 5.91% | +$903.7K |
| argenx SEADR(ARGX) | 4,705 | 5,558 | +853 | $4.37M | $5.33M | 4.11% | +$964.5K |
| Arrivent Biopharma Inc | 218,694 | 170,893 | -47,801 | $7.60M | $5.17M | 3.99% | -$2.42M |
| Surrozen Inc | 173,395 | 152,541 | -20,854 | $4.50M | $4.91M | 3.79% | +$409.2K |
| Vogenx Inc | 0 | 213,186 | +213,186 | $0 | $4.86M | 3.75% | +$4.86M |
| Bright Minds Biosciences Inc | 92,745 | 93,152 | +407 | $6.51M | $4.64M | 3.58% | -$1.87M |
| Ocular Therapeutix, Inc.(OCUL) | 532,481 | 574,543 | +42,062 | $5.23M | $4.41M | 3.40% | -$822.2K |
| Silence Therapeutics plcADS(SLN) | 0 | 393,583 | +393,583 | $0 | $4.30M | 3.32% | +$4.30M |
| Taysha Gene Therapies, Inc.(TSHA) | 561,808 | 691,843 | +130,035 | $3.83M | $3.37M | 2.60% | -$456.6K |
| Avalyn Pharma Inc | 115,000 | 114,749 | -251 | $3.79M | $3.27M | 2.52% | -$516.6K |
| Avalo Therapeutics Inc | 186,308 | 186,308 | 0 | $3.44M | $2.86M | 2.20% | -$586.9K |
| MoonLake ImmunotherapeuticsCLASS ORD A(MLTX) | 215,652 | 216,568 | +916 | $4.20M | $2.53M | 1.96% | -$1.66M |
| Opus Genetics Inc | 0 | 514,110 | +514,110 | $0 | $2.49M | 1.92% | +$2.49M |
| Minerva Neurosciences | 709,500 | 729,500 | +20,000 | $3.94M | $2.44M | 1.89% | -$1.49M |
| LB Pharmaceuticals Inc(LBRX) | 28,919 | 52,718 | +23,799 | $938.6K | $2.02M | 1.56% | +$1.08M |
| Artiva Biotherapeutics Inc | 260,416 | 260,416 | 0 | $2.53M | $1.85M | 1.43% | -$671.9K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 168,115 | 62,956 | -105,159 | $3.02M | $1.83M | 1.41% | -$1.19M |
| Revolution Medicines, Inc.(RVMD) | 0 | 8,237 | +8,237 | $0 | $1.69M | 1.30% | +$1.69M |
| Irulya Therapeutics Inc | 0 | 52,918 | +52,918 | $0 | $1.64M | 1.27% | +$1.64M |
| Roivant Sciences Ltd.SHS(ROIV) | 0 | 41,535 | +41,535 | $0 | $1.52M | 1.17% | +$1.52M |
| Design Therapeutics Inc | 282,564 | 115,392 | -167,172 | $4.09M | $1.45M | 1.12% | -$2.64M |
| United Therapeutics Corporation(UTHR) | 2,224 | 2,240 | +16 | $1.21M | $1.21M | 0.94% | +$8.8K |
| Contineum Therapeutics Inc-ACL A | 63,095 | 89,826 | +26,731 | $1.03M | $1.21M | 0.93% | +$171.3K |
| Oric Pharmaceuticals Inc | 0 | 87,918 | +87,918 | $0 | $1.18M | 0.91% | +$1.18M |
| Erasca, Inc.(ERAS) | 265,199 | 67,541 | -197,658 | $4.86M | $990.2K | 0.76% | -$3.87M |
| An2 Therapeutics Inc | 0 | 142,051 | +142,051 | $0 | $755.7K | 0.58% | +$755.7K |
| Adial Pharmaceuticals Inc | 0 | 129,982 | +129,982 | $0 | $521.2K | 0.40% | +$521.2K |
| Sutro Biopharma Inc | 270,251 | 25,290 | -244,961 | $8.97M | $407.4K | 0.31% | -$8.56M |
| Equillium Inc | 0 | 183,000 | +183,000 | $0 | $297.4K | 0.23% | +$297.4K |
| Compass Therapeutics Inc | 595,213 | 251,001 | -344,212 | $1.30M | $261.0K | 0.20% | -$1.04M |
| Stoke Therapeutics, Inc.(STOK) | 0 | 5,771 | +5,771 | $0 | $150.0K | 0.12% | +$150.0K |